Integra Lifesciences Holdings Corp · Operating Cash Flow (Statement)

Latest reported$85.33Mperiod endingJun 30, 2026

IART Cash from Operations (-$5.60M → $85.33M)

Annual operating cash flow (statement)

High-resolution chart · PNG

IART operating cash flow (statement) history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Integra Lifesciences Holdings Corp Operating Cash Flow (Statement) — Annual fiscal periods (USD)
Period ending	Operating Cash Flow (Statement) (USD)
Dec 31, 2025	50,384,000
Dec 31, 2024	129,382,000
Dec 31, 2023	139,955,000
Dec 31, 2022	264,469,000
Dec 31, 2021	312,427,000
Dec 31, 2020	203,832,000
Dec 31, 2019	231,433,000
Dec 31, 2018	199,683,000
Dec 31, 2017	114,544,000
Dec 31, 2016	116,405,000
Dec 31, 2015	94,483,000
Dec 31, 2014	79,463,000
Dec 31, 2013	53,268,000
Dec 31, 2012	58,715,000
Dec 31, 2011	104,328,000
Dec 31, 2010	105,571,000
Dec 31, 2009	143,235,000
Dec 31, 2008	72,590,000
Dec 31, 2007	47,026,000
Dec 31, 2006	71,702,000
Dec 31, 2005	56,848,000
Dec 31, 2004	38,975,000
Dec 31, 2003	34,826,000
Dec 31, 2002	31,985,000
Dec 31, 2001	15,701,000
Dec 31, 2000	-4,960,000
Dec 31, 1999	2,500,000
Dec 31, 1998	-9,800,000
Dec 31, 1997	-7,900,000
Dec 31, 1996	-8,000,000
Dec 31, 1995	-5,600,000